USD 7.41
(19.71%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 6.65 Million USD | -23.86% |
2022 | 8.73 Million USD | 16.03% |
2021 | 7.53 Million USD | -17.51% |
2020 | 9.12 Million USD | 194.07% |
2019 | 3.1 Million USD | 23.57% |
2018 | 2.51 Million USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q3 | 4.76 Million USD | -14.57% |
2024 Q1 | 6.57 Million USD | -1.11% |
2024 Q2 | 5.57 Million USD | -15.28% |
2023 Q1 | 8.43 Million USD | -3.42% |
2023 FY | 6.65 Million USD | -23.86% |
2023 Q4 | 6.65 Million USD | -15.07% |
2023 Q3 | 7.83 Million USD | -8.2% |
2023 Q2 | 8.53 Million USD | 1.11% |
2022 Q2 | 7.92 Million USD | -1.3% |
2022 Q1 | 8.02 Million USD | 6.57% |
2022 FY | 8.73 Million USD | 16.03% |
2022 Q4 | 8.73 Million USD | 9.64% |
2022 Q3 | 7.96 Million USD | 0.61% |
2021 FY | 7.53 Million USD | -17.51% |
2021 Q4 | 7.53 Million USD | -17.25% |
2021 Q3 | 9.1 Million USD | 1.92% |
2021 Q2 | 8.92 Million USD | -4.67% |
2021 Q1 | 9.36 Million USD | 2.61% |
2020 Q1 | 3.71 Million USD | 19.72% |
2020 Q4 | 9.12 Million USD | 17.4% |
2020 Q3 | 7.77 Million USD | 49.2% |
2020 Q2 | 5.21 Million USD | 40.23% |
2020 FY | 9.12 Million USD | 194.07% |
2019 FY | 3.1 Million USD | 23.57% |
2019 Q4 | 3.1 Million USD | 0.0% |
2018 FY | 2.51 Million USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Doximity, Inc. | - USD | -Infinity% |
Evolent Health, Inc. | 1.00 USD | -665199900.0% |
MultiPlan Corporation | -1.82 Million USD | 465.094% |
Phreesia, Inc. | - USD | -Infinity% |
Teladoc Health, Inc. | 29.51 Million USD | 77.461% |
Veeva Systems Inc. | - USD | -Infinity% |